nach oben

Erschienen in:

27.04.2023 | Original Article

Consumption of health resources in older people with differentiated thyroid carcinoma: a multicenter analysis

verfasst von: Juan J. Díez, Emma Anda, Victoria Alcazar, María L. Isidro, Cristina Familiar, Miguel Paja, Patricia Martín Rojas-Marcos, Begoña Pérez-Corral, Elena Navarro, Ana R. Romero-Lluch, Amelia Oleaga, María J. Pamplona, José C. Fernández-García, Ana Megía, Laura Manjón-Miguélez, Cecilia Sánchez-Ragnarsson, Pedro Iglesias, Julia Sastre

Erschienen in: Endocrine | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

There is hardly any information on the consumption of healthcare resources by older people with differentiated thyroid cancer (DTC). We analyzed these consumptions in older patients with DTC and compared patients 75 years and older with subjects aged 60–74 years.

Methods

A multicenter, retrospective analysis was designed. We recorded three groups of health resources consumption (visits, diagnostic procedures, and therapeutic procedures) and identified a subgroup of patients with high consumption of resources. We compared patients aged between 60–74 years (group 1) with patients aged 75 and over (group 2).

Results

We included 1654 patients (women, 74.4%), of whom 1388 (83.9%) belonged to group 1 and 266 (16.1%) to group 2. In group 2, we found a higher proportion of patients requiring emergency department visits (7.9 vs. 4.3%, P = 0.019) and imaging studies (24.1 vs. 17.3%; P = 0.012) compared to group 1. However, we did not find any significant difference between both groups in the consumption of other visits, diagnostic procedures, or therapeutic procedures. Overall, 340 patients (20.6%) were identified as high consumers of health resources, 270 (19.5%) in group 1 and 70 (26.3%) in group 2 (P = 0.013). Multivariate logistic regression analysis showed that the risk of recurrence and mortality, radioiodine treatment, tumor size, and vascular invasion were significantly related to the high global consumption of resources. However, the age was not significantly related to it.

Conclusion

In patients with DTC over 60 years of age, advanced age is not an independent determining factor in the consumption of health resources.

Nur mit Berechtigung zugänglich

M. Pizzato, M. Li, J. Vignat, M. Laversanne, D. Singh, C. La Vecchia, S. Vaccarella, The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 10(4), 264–272 (2022). https://doi.org/10.1016/S2213-8587(22)00035-3CrossRefPubMed

L. Leenhardt, M.O. Bernier, M.H. Boin-Pineau, B. Conte Devolx, R. Maréchaud, P. Niccoli-Sire, M. Nocaudie, J. Orgiazzi, M. Schlumberger, J.L. Wémeau, L. Chérie-Challine, F. De Vathaire, Advances in diagnostic practices affect thyroid cancer incidence in France. Eur. J. Endocrinol. 150(2), 133–9 (2004). https://doi.org/10.1530/eje.0.1500133CrossRefPubMed

L. Davies, H.G. Welch, Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295(18), 2164–7 (2006). https://doi.org/10.1001/jama.295.18.2164CrossRefPubMed

S.R. Baker, W.A. Bhatti, The thyroid cancer epidemic: is it the dark side of the CT revolution. Eur. J. Radiol. 60(1), 67–9 (2006). https://doi.org/10.1016/j.ejrad.2006.04.022CrossRefPubMed

N. Mevawalla, T. McMullen, S. Sidhu, M. Sywak, B. Robinson, L. Delbridge, Presentation of clinically solitary thyroid nodules in surgical patients. Thyroid 21(1), 55–9 (2011). https://doi.org/10.1089/thy.2009.0230CrossRefPubMed

B. Amato, R. Compagna, L. Sivero, A. Rocca, M. Donisi, Lymphectomy for elderly in thyroid surgery. Chir 26(4), 303–6 (2013. https://www.minervamedica.it/en/journals/chirurgia/article.php?cod=R20Y2013N04A0303

F.A. Verburg, U. Mäder, K. Tanase, E.D. Thies, S. Diessl, A.K. Buck, M. Luster, C. Reiners, Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J. Clin. Endocrinol. Metab. 98(1), 172–80 (2013). https://doi.org/10.1210/jc.2012-2458CrossRefPubMed

E.L. Mazzaferri, Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr. Pract. 6(6), 469–76 (2000). https://doi.org/10.4158/EP.6.6.469CrossRefPubMed

R.H. Grogan, S.P. Kaplan, H. Cao, R.E. Weiss, L.J. Degroot, C.A. Simon, O.M. Embia, P. Angelos, E.L. Kaplan, R.B. Schechter, A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up. Surgery 154(6), 1436–46 (2013). https://doi.org/10.1016/j.surg.2013.07.008. discussion 1446-7CrossRefPubMed

10.

M. Raffaelli, R. Bellantone, P. Princi, C. De Crea, E.D. Rossi, G. Fadda, C.P. Lombardi, Surgical treatment of thyroid diseases in elderly patients. Am. J. Surg. 200(4), 467–72 (2010). https://doi.org/10.1016/j.amjsurg.2009.12.020CrossRefPubMed

11.

M.C. Coburn, H.J. Wanebo, Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am. J. Surg. 170(5), 471–5 (1995). https://doi.org/10.1016/s0002-9610(99)80332-8CrossRefPubMed

12.

K.M. van Tol, E.G. de Vries, R.P. Dullaart, T.P. Links, Differentiated thyroid carcinoma in the elderly. Crit. Rev. Oncol. Hematol. 38(1), 79–91 (2001). https://doi.org/10.1016/s1040-8428(00)00127-xCrossRefPubMed

13.

L. Vini, S.L. Hyer, J. Marshall, R. A’Hern, C. Harmer, Long-term results in elderly patients with differentiated thyroid carcinoma. Cancer 97(11), 2736–42 (2003). https://doi.org/10.1002/cncr.11410CrossRefPubMed

14.

J.D. Lin, T.C. Chao, S.T. Chen, H.F. Weng, K.D. Lin, Characteristics of thyroid carcinomas in aging patients. Eur. J. Clin. Invest 30(2), 147–53 (2000). https://doi.org/10.1046/j.1365-2362.2000.00598.xCrossRefPubMed

15.

H.S. Park, S.A. Roman, J.A. Sosa, Treatment patterns of aging Americans with differentiated thyroid cancer. Cancer 116(1), 20–30 (2010). https://doi.org/10.1002/cncr.24717CrossRefPubMed

16.

P.G. Calò, F. Medas, G. Loi, E. Erdas, G. Pisano, A. Nicolosi, Differentiated thyroid cancer in the elderly: our experience. Int. J. Surg. 12(2), S140–S143 (2014). https://doi.org/10.1016/j.ijsu.2014.08.362CrossRefPubMed

17.

F.D. Dellal, D. Özdemir, A.A. Tam, H. Baser, H. Tatli Dogan, O. Parlak, R. Ersoy, B. Cakir, Clinicopathological features of thyroid cancer in the elderly compared to younger counterparts: single-center experience. J. Endocrinol. Invest 40(5), 471–479 (2017). https://doi.org/10.1007/s40618-016-0577-7CrossRefPubMed

18.

L. Falvo, A. Catania, S. Sorrenti, V. D’Andrea, A. Berni, M. De Stefano, E. De Antoni, Prognostic significance of the age factor in the thyroid cancer: statistical analysis. J. Surg. Oncol. 88(4), 217–22 (2004). https://doi.org/10.1002/jso.20140CrossRefPubMed

19.

C.S. Hollenbeak, M.M. Boltz, E.W. Schaefer, B.D. Saunders, D. Goldenberg, Recurrence of differentiated thyroid cancer in the elderly. Eur. J. Endocrinol. 168(4), 549–56 (2013). https://doi.org/10.1530/EJE-12-0848CrossRefPubMed

20.

A. Toniato, C. Bernardi, A. Piotto, D. Rubello, M.R. Pelizzo, Features of papillary thyroid carcinoma in patients older than 75 years. Updates Surg. 63(2), 115–8 (2011). https://doi.org/10.1007/s13304-011-0060-0CrossRefPubMed

21.

M. Papaleontiou, M.R. Haymart, Approach to and treatment of thyroid disorders in the elderly. Med. Clin. North Am. 96(2), 297–310 (2012). https://doi.org/10.1016/j.mcna.2012.01.013CrossRefPubMedPubMedCentral

22.

P. Trimboli, A. Piccardo, A. Signore, S. Valabrega, A. Barnabei, G. Santolamazza, A. Di Paolo, V. Stati, A. Chiefari, S. Vottari, M. Simmaco, G. Ferrarazzo, L. Ceriani, M. Appetecchia, L. Giovanella, Patient Age Is an Independent Risk Factor of Relapse of Differentiated Thyroid Carcinoma and Improves the Performance of the American Thyroid Association Stratification System. Thyroid 30(5), 713–719 (2020). https://doi.org/10.1089/thy.2019.0688CrossRefPubMed

23.

J.M. Wiener, J. Tilly, Population ageing in the United States of America: implications for public programmes. Int. J. Epidemiol. 31(4), 776–81 (2002). https://doi.org/10.1093/ije/31.4.776CrossRefPubMed

24.

World Health Organization. World Report on Ageing and Health. WHO, 2015. Available at: https://apps.who.int/iris/bitstream/handle/10665/186463/9789240694811_eng.pdf?sequence=1&isAllowed=y. Visited on December 11, 2022.

25.

Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery; European Society of Cardiology (ESC), D. Poldermans, J.J. Bax, E. Boersma, S. De Hert, E. Eeckhout, G. Fowkes, B. Gorenek, M.G. Hennerici, B. Iung, M. Kelm, K.P. Kjeldsen, S.D. Kristensen, J. Lopez-Sendon, P. Pelosi, F. Philippe, L. Pierard, P. Ponikowski, J.P. Schmid, O.F. Sellevold, R. Sicari, G. Van den Berghe, F. Vermassen, Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur. Heart J. 30(22), 2769–812 (2009). https://doi.org/10.1093/eurheartj/ehp337CrossRefPubMed

26.

E.O. Hoogendijk, J. Afilalo, K.E. Ensrud, P. Kowal, G. Onder, L.P. Fried, Frailty: implications for clinical practice and public health. Lancet. 394(10206), 1365–1375 (2019). https://doi.org/10.1016/S0140-6736(19)31786-6CrossRefPubMed

27.

J.J. Díez, E. Anda, V. Alcazar, M.L. Isidro, C. Familiar, M. Paja, P. Rojas Marcos, B. Pérez-Corral, E. Navarro, A.R. Romero-Lluch, A. Oleaga, M.J. Pamplona, J.C. Fernández-García, A. Megía, L. Manjón, C. Sánchez-Ragnarsson, P. Iglesias, J. Sastre, Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival. Endocrine 77(1), 121–133 (2022). https://doi.org/10.1007/s12020-022-03059-yCrossRefPubMed

28.

M.M. Boltz, C.S. Hollenbeak, E. Schaefer, D. Goldenberg, B.D. Saunders, Attributable costs of differentiated thyroid cancer in the elderly Medicare population. Surgery 154(6), 1363–9 (2013). https://doi.org/10.1016/j.surg.2013.06.042. discussion 1369-70CrossRefPubMed

29.

M.M. Tuttle, B. Haugen, J. Shah, J.A. Sosa, E. Rohren, R.M. Subramaniam, J.L.P.N. Hunt. Thyroid differentiated and anaplastic carcinoma. AJCC Cancer Staging Manual. S. Amin MB Edge, F. Greene, ByrdDR, R.K. Brookland, M.K. Washington, J.E. Gershenwald, C.C. Compton, K.R. Hess, D.C. Sullivan, J.M. Jessup, J.D. Brierley, L.E. Gaspar, R.L. Schilsky, C.M. Balch, D.P. Winchester, E.A. Asare, M. Madera, D.M. Gress, L.R. Meyer eds. Springer International, New York, NY), 2017).

30.

B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1), 1–133 (2016). https://doi.org/10.1089/thy.2015.0020CrossRefPubMedPubMedCentral

31.

R.L. Brown, J.A. de Souza, E.E. Cohen, Thyroid cancer: burden of illness and management of disease. J. Cancer 2, 193–9 (2011). https://doi.org/10.7150/jca.2.193CrossRefPubMedPubMedCentral

32.

H.P. Kale, D.P. Mays, P.A. Nadpara, P.W. Slattum, A.K. Paul, N.V. Carroll, Economic burden of renal cell carcinoma among older adults in the targeted therapy era. Urol. Oncol. 37(6), 356.e19–356.e28 (2019). https://doi.org/10.1016/j.urolonc.2019.01.016CrossRefPubMed

33.

C.S. Hollenbeak, L.E. Nikkel, E.W. Schaefer, E. Alemao, N. Ghahramani, J.D. Raman, Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma. J. Manag. Care Pharm. 17(8), 610–20 (2011). https://doi.org/10.18553/jmcp.2011.17.8.610CrossRefPubMedPubMedCentral

34.

J.J. Díez, L. Cabrera, P. Iglesias et al. Carcinoma de tiroides en personas mayores: caracterización mediante herramientas de big data, Endocrinología, Diabetes y Nutrición, https://doi.org/10.1016/j.endinu.2022.11.003

35.

R.H. Grogan, E.J. Mitmaker, J. Hwang, J.E. Gosnell, Q.Y. Duh, O.H. Clark, W.T. Shen, A population-based prospective cohort study of complications after thyroidectomy in the elderly. J. Clin. Endocrinol. Metab. 97(5), 1645–53 (2012). https://doi.org/10.1210/jc.2011-1162CrossRefPubMed

36.

S.H. Ng, K.P. Wong, B.H. Lang, Thyroid surgery for elderly patients: are they at increased operative risks? J. Thyroid Res. 2012, 946276 (2012). https://doi.org/10.1155/2012/946276CrossRefPubMedPubMedCentral

37.

M. Mekel, A.E. Stephen, R.D. Gaz, Z.H. Perry, R.A. Hodin, S. Parangi, Thyroid surgery in octogenarians is associated with higher complication rates. Surgery 146(5), 913–21 (2009). https://doi.org/10.1016/j.surg.2009.05.004CrossRefPubMed

38.

K. Marvin, K. Parham, Differentiated thyroid cancer in people aged 85 and older. J. Am. Geriatr. Soc. 63(5), 932–7 (2015). https://doi.org/10.1111/jgs.13397CrossRefPubMed

39.

D. Inversini, A. Morlacchi, G. Melita, S. Del Ferraro, C. Boeri, M. Portinari, A. Cancellieri, F. Frattini, A.G. Rizzo, G. Dionigi, Thyroidectomy in elderly patients aged ≥70 years. Gland Surg. 6(5), 587–590 (2017). https://doi.org/10.21037/gs.2017.10.01CrossRefPubMedPubMedCentral

40.

M.G. Shrime, D.P. Goldstein, R.M. Seaberg, A.M. Sawka, L. Rotstein, J.L. Freeman, P.J. Gullane, Cost-effective management of low-risk papillary thyroid carcinoma. Arch. Otolaryngol. Head Neck Surg. 133(12), 1245–53 (2007). https://doi.org/10.1001/archotol.133.12.1245CrossRefPubMed

41.

P. Miccoli, L. Fregoli, R. Rago, V. Matteucci, M. Miccoli, G. Materazzi, Increased costs of perioperative risk assessment for thyroid surgery in elderly people (over 80 years) presenting with benign disease. Langenbecks Arch. Surg. 398(4), 525–30 (2013). https://doi.org/10.1007/s00423-013-1075-4CrossRefPubMed

42.

A.R. Donizzetti, Ageism in an aging society: the role of knowledge, anxiety about aging, and stereotypes in young people and adults. Int. J. Environ. Res. Public Health 16(8), 1329 (2019). https://doi.org/10.3390/ijerph16081329CrossRefPubMedPubMedCentral

43.

J.L. Kuijpens, M.L. Janssen-Heijnen, V.E. Lemmens, H.R. Haak, A.C. Heijckmann, J.W. Coebergh, Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival. Clin. Endocrinol. (Oxf) 64(4), 450–5 (2006). https://doi.org/10.1111/j.1365-2265.2006.02492.xCrossRefPubMed

44.

World Health Organization. Global report on ageism. Available at: https://www.who.int/publications/i/item/9789240016866. Visited on December 14, 2022.

Titel: Consumption of health resources in older people with differentiated thyroid carcinoma: a multicenter analysis
verfasst von: Juan J. Díez
Emma Anda
Victoria Alcazar
María L. Isidro
Cristina Familiar
Miguel Paja
Patricia Martín Rojas-Marcos
Begoña Pérez-Corral
Elena Navarro
Ana R. Romero-Lluch
Amelia Oleaga
María J. Pamplona
José C. Fernández-García
Ana Megía
Laura Manjón-Miguélez
Cecilia Sánchez-Ragnarsson
Pedro Iglesias
Julia Sastre
Publikationsdatum: 27.04.2023
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2023
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-023-03369-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Consumption of health resources in older people with differentiated thyroid carcinoma: a multicenter analysis